Perspective Therapeutics Stock Analysis

Perspective Stock Analysis Notes

About 60.0% of the company shares are held by institutions such as insurance companies. The book value of Perspective Therapeutics was currently reported as 3.26. The company recorded a loss per share of 1.51. Perspective Therapeutics had not issued any dividends in recent years. The entity had 1:10 split on the 17th of June 2024. For more info on Perspective Therapeutics please contact Johan Spoor at 206 676 0900 or go to https://www.perspectivetherapeutics.com.

Perspective Therapeutics Investment Alerts

Perspective Largest EPS Surprises

View All Earnings Estimates

Perspective Therapeutics Environmental, Social, and Governance (ESG) Scores

Perspective Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 535.4 M.

Perspective Profitablity

Management Efficiency

Perspective Therapeutics has return on total asset (ROA) of (0.1724) % which means that it has lost $0.1724 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3726) %, meaning that it created substantial loss on money invested by shareholders. Perspective Therapeutics' management efficiency ratios could be used to measure how well Perspective Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to rise to 0.04 in 2026, despite the fact that Return On Tangible Assets are likely to grow to (0.30). At this time, Perspective Therapeutics' Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 132.8 M in 2026, whereas Non Currrent Assets Other are likely to drop slightly above 300.9 K in 2026.

Technical Drivers

As of the 14th of February 2026, Perspective Therapeutics holds the Risk Adjusted Performance of 0.1312, coefficient of variation of 661.38, and Semi Deviation of 5.01. Perspective Therapeutics technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices.

Perspective Therapeutics Price Movement Analysis

Perspective Therapeutics Insider Trading Activities

Perspective Therapeutics Outstanding Bonds

Perspective Therapeutics Predictive Daily Indicators

Perspective Therapeutics Forecast Models

Perspective Therapeutics' time-series forecasting models are one of many Perspective Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Perspective Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Perspective Therapeutics Bond Ratings

Perspective Therapeutics financial ratings play a critical role in determining how much Perspective Therapeutics have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Perspective Therapeutics' borrowing costs.

Perspective Therapeutics Total Assets Over Time

Perspective Therapeutics Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Perspective Therapeutics uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Perspective Therapeutics Debt Ratio

1.3

It appears most of the Perspective Therapeutics' assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Perspective Therapeutics' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Perspective Therapeutics, which in turn will lower the firm's financial flexibility.

Perspective Therapeutics Corporate Bonds Issued

Perspective Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Perspective Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Perspective shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Perspective Therapeutics. By using and applying Perspective Stock analysis, traders can create a robust methodology for identifying Perspective entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Perspective analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Perspective analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Perspective Therapeutics stock analysis indicators help investors evaluate how Perspective Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Perspective Therapeutics shares will generate the highest return on investment. By understating and applying Perspective Therapeutics stock analysis, traders can identify Perspective Therapeutics position entry and exit signals to maximize returns.

When running Perspective Therapeutics' price analysis, check to measure Perspective Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Perspective Therapeutics is operating at the current time. Most of Perspective Therapeutics' value examination focuses on studying past and present price action to predict the probability of Perspective Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Perspective Therapeutics' price. Additionally, you may evaluate how the addition of Perspective Therapeutics to your portfolios can decrease your overall portfolio volatility.